ValitaCell Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 2

ValitaCell General Information

Description

Provider of biotechnology services intended to improve the efficiency and performance of cell development. The company's biotechnology services include antibody titer, fluorescence polarisation, and clone selection to treat diseases such as cancer, cardiovascular disease, and a number of rare illnesses, enabling clients to bring innovative medicines to the market faster, cheaper, and with greater regulatory confidence.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • NIBRT, Fosters Avenue
  • Mount Merrion, Blackrock
  • Dublin A94 X099
  • Ireland
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • NIBRT, Fosters Avenue
  • Mount Merrion, Blackrock
  • Dublin A94 X099
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ValitaCell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 13-Sep-2022 Completed Generating Revenue
5. Accelerator/Incubator 19-Mar-2021 Completed Generating Revenue
4. Grant 15-Jun-2017 Completed Generating Revenue
3. Early Stage VC 05-Dec-2016 Completed Generating Revenue
2. Grant 24-Nov-2016 $130K $1.46M Completed Generating Revenue
1. Angel (individual) 30-Aug-2016 $1.46M $1.46M Completed Generating Revenue
To view ValitaCell’s complete valuation and funding history, request access »

ValitaCell Patents

ValitaCell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4634828-A1 A method for evaluating trust of convolutional neural network outputs Active 12-Dec-2022
EP-4634828-B1 A method for evaluating trust of convolutional neural network outputs Active 12-Dec-2022
EP-4634828-C0 A method for evaluating trust of convolutional neural network outputs Active 12-Dec-2022
US-20260203557-A1 A method for evaluating trust of convolutional neural network outputs Pending 12-Dec-2022
WO-2024126531-A1 A method for evaluating trust of convolutional neural network outputs Inactive 12-Dec-2022 G06N3/0464
To view ValitaCell’s complete patent history, request access »

ValitaCell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ValitaCell Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Enterprise Ireland Growth/Expansion Minority
Angel (individual) Minority
Plug and Play Accelerator/Incubator Minority
Startup Creasphere Accelerator/Incubator Minority
To view ValitaCell’s complete investors history, request access »

ValitaCell FAQs

  • When was ValitaCell founded?

    ValitaCell was founded in 2014.

  • Where is ValitaCell headquartered?

    ValitaCell is headquartered in Dublin, Ireland.

  • What is the size of ValitaCell?

    ValitaCell has 20 total employees.

  • What industry is ValitaCell in?

    ValitaCell’s primary industry is Discovery Tools (Healthcare).

  • Is ValitaCell a private or public company?

    ValitaCell is a Private company.

  • What is ValitaCell’s current revenue?

    The current revenue for ValitaCell is .

  • How much funding has ValitaCell raised over time?

    ValitaCell has raised $3.1M.

  • Who are ValitaCell’s investors?

    Enterprise Ireland, , Plug and Play, and Startup Creasphere have invested in ValitaCell.

  • When was ValitaCell acquired?

    ValitaCell was acquired on 13-Sep-2022.

  • Who acquired ValitaCell?

    ValitaCell was acquired by Beckman Coulter.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process